OXYBUTYNIN (oxybutynin) by AbbVie is muscle. Approved for older with symptoms of detrusor overactivity associated with a neurological condition (e, overactive bladder with symptoms of urge urinary incontinence, urgency and 1 more indications. First approved in 2014.
Drug data last refreshed 3d ago
muscle. Oxybutynin chloride exerts a direct antispasmodic effect on smooth muscle and inhibits the muscarinic action of acetylcholine on smooth muscle. No blocking effects occur at skeletal neuromuscular junctions or autonomic ganglia (antinicotinic effects). Antimuscarinic activity resides…
Worked on OXYBUTYNIN at AbbVie? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Efficacy of Intravesical Oxybutynin in Children With Neurogenic Bladder Dysfunction
Testing the Effects of Oxybutynin for the Treatment of Hot Flashes in Men Receiving Hormone Therapy for Prostate Cancer
Oxybutynin Chloride in Managing Hot Flashes
A Study of Fesoterodine and Oxybutynin on Cognitive Function in Mild Cognitive Impairment
A Pilot Study Exploring the Efficacy and Safety of Topical Oxybutynin 3% Gel for Primary Focal Hyperhidrosis in Adolescents and Young Adults